China Study Says More Than Half Of Men Aged 60 And Over Have BPH
This article was originally published in PharmAsia News
A Chinese study concludes that more than half of the nation’s men over 60 have benign prostatic hyperplasia, reflecting an expected surge in cases due to a rapidly aging population.
You may also be interested in...
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.
The FDA emphasized the rigor of its review of the first COVID-19 therapy, which used few expedited pathways on its way to approval after a two-and-a-half-month review. Post-marketing studies will address remaining concerns about dosing and special populations.